Education
About Us
Working with TipRanks
Follow Us
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
RESEARCH TOOLSreports
| Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 16.70B | ₹ 16.84B | ₹ 15.24B | ₹ 16.69B | ₹ 15.43B |
| Gross Profit | ₹ 3.02B | ₹ 4.82B | ₹ 579.91M | ₹ 2.99B | ₹ 2.58B |
| Operating Income | ₹ -888.47M | ₹ 3.89B | ₹ -51.73M | ₹ 1.02B | ₹ 620.13M |
| EBITDA | ₹ -245.66M | ₹ 1.69B | ₹ 994.97M | ₹ 1.61B | ₹ 612.51M |
| Net Income | ₹ -1.14B | ₹ 49.95M | ₹ -241.83M | ₹ 250.47M | ₹ -732.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 272.63M | ₹ 203.01M | ₹ 178.94M | ₹ 182.35M | ₹ 259.58M |
| Total Assets | ₹ 20.47B | ₹ 21.91B | ₹ 21.89B | ₹ 23.91B | ₹ 23.88B |
| Total Debt | ₹ 5.82B | ₹ 6.36B | ₹ 7.54B | ₹ 8.60B | ₹ 9.03B |
| Net Debt | ₹ 5.63B | ₹ 6.16B | ₹ 7.36B | ₹ 8.42B | ₹ 8.78B |
| Total Liabilities | ₹ 10.91B | ₹ 11.22B | ₹ 11.25B | ₹ 13.03B | ₹ 13.26B |
| Stockholders' Equity | ₹ 9.56B | ₹ 10.69B | ₹ 10.65B | ₹ 10.88B | ₹ 10.62B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 1.26B | ₹ 1.95B | ₹ 1.04B | ₹ 700.35M | ₹ -98.62M |
| Operating Cash Flow | ₹ 1.69B | ₹ 2.25B | ₹ 1.34B | ₹ 950.05M | ₹ 213.79M |
| Investing Cash Flow | ₹ -419.30M | ₹ -170.25M | ₹ 517.04M | ₹ 166.44M | ₹ -286.24M |
| Financing Cash Flow | ₹ -1.28B | ₹ -2.05B | ₹ -1.86B | ₹ -1.19B | ₹ 114.90M |
Nectar Lifesciences Ltd. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.